Bronchopulmonary Dysplasia (BPD) Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting bronchopulmonary dysplasia (bpd) clinical trials across 5 countries. Studies span Early Phase 1, Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Amherst, Massachusetts, United States, Atlanta, Georgia, United States, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Bronchopulmonary Dysplasia (BPD) Trials at a Glance

7 actively recruiting trials for bronchopulmonary dysplasia (bpd) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Early Phase 1 with 1 trial, with the heaviest enrollment activity in Amherst, Atlanta, and Birmingham. Lead sponsors running bronchopulmonary dysplasia (bpd) studies include Duke University, Global Foundation for the Care of Newborn Infants, and Aristotle University Of Thessaloniki.

Browse bronchopulmonary dysplasia (bpd) trials by phase

Treatments under study

About Bronchopulmonary Dysplasia (BPD) Clinical Trials

Looking for clinical trials for Bronchopulmonary Dysplasia (BPD)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchopulmonary Dysplasia (BPD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchopulmonary Dysplasia (BPD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1Phase 2

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Critical IllnessBronchopulmonary Dysplasia (BPD)Premature Births
Duke University28 enrolled5 locationsNCT07101640
Recruiting
Not Applicable

Continued Pressure for Alveolar Protection (CPAP Trial)

Bronchopulmonary Dysplasia (BPD)
NICHD Neonatal Research Network860 enrolled15 locationsNCT07417111
Recruiting
Phase 4

Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants

Bronchopulmonary Dysplasia (BPD)
Aristotle University Of Thessaloniki74 enrolled1 locationNCT07652684
Recruiting

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

Intraventricular hemorrhageDeathPulmonary Hemorrhage+5 more
University Hospital, Montpellier30 enrolled1 locationNCT07273643
Recruiting

National Surveillance and Prevention of Neonatal VAP

Bronchopulmonary Dysplasia (BPD)Ventilator-Associated Pneumonia (VAP), NeonatalAntibiotic-Resistant Organisms (AROs)+1 more
University of Alberta1,500 enrolled1 locationNCT07109791
Recruiting
Early Phase 1

Metformin for Premature Infants With Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia (BPD)
Medical College of Wisconsin40 enrolled1 locationNCT07120971
Recruiting

Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)

Bronchopulmonary Dysplasia (BPD)Chronic Lung Disease of NewbornHRQOL (Health Related Quality Of Life)
Global Foundation for the Care of Newborn Infants480 enrolled1 locationNCT07134387